publication date: Sep 23, 2014
|
author/source: Bioquell
Today, areas in the High Level Isolation Unit at the Royal Free Hospital, where a patient was recently treated for Ebola Virus Disease have been sterilised using hydrogen peroxide vapour producing ‘robots’.
The effectiveness of the technology, designed and produced by UK company Bioquell, has been extensively evaluated by the NHS. The system has been deployed globally during the current outbreak.
The portable, automated system uses 35% hydrogen peroxide, which is distributed as a vapour throughout the decontamination area, ensuring full three-dimensional coverage. The peroxide is then removed, allowing admission of another patient within 90 minutes.
Speaking today, James Salkeld, Head of Healthcare at Bioquell, said “With a pathogen such as Ebola, totally eliminating any risk of residual contamination is clearly of paramount importance. It is encouraging that hospitals are now adopting the same zero tolerance mindset towards more common pathogens such as MRSA and C.diff, routinely using this technology after patient discharge.”
more about bioquell
more news from bioquell
Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!
Request your free copies HERE
Popular this Month
Top 10 most popular articles this month
Today's Picks
Looking for a Supplier?
Search by company or by product
Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.
Lab Bulletin is published by newleaf marketing communications ltd.